nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SLC6A4—conduct disorder	0.967	1	CbGaD
Fluvoxamine—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.00509	0.153	CbGpPWpGaD
Fluvoxamine—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.00506	0.152	CbGpPWpGaD
Fluvoxamine—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00235	0.0705	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00232	0.0697	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00231	0.0693	CbGpPWpGaD
Fluvoxamine—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.00101	0.0304	CbGpPWpGaD
Fluvoxamine—CYP1A2—Methylation—COMT—conduct disorder	0.000771	0.0232	CbGpPWpGaD
Fluvoxamine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.000756	0.0227	CbGpPWpGaD
Fluvoxamine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.000513	0.0154	CbGpPWpGaD
Fluvoxamine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.000499	0.015	CbGpPWpGaD
Fluvoxamine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000482	0.0145	CbGpPWpGaD
Fluvoxamine—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000419	0.0126	CbGpPWpGaD
Fluvoxamine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000386	0.0116	CbGpPWpGaD
Fluvoxamine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000372	0.0112	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000368	0.011	CbGpPWpGaD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00034	0.0102	CbGpPWpGaD
Fluvoxamine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000327	0.00981	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.0003	0.00901	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.000287	0.00861	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.000282	0.00845	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000281	0.00844	CbGpPWpGaD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000252	0.00755	CbGpPWpGaD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000246	0.00739	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000246	0.00738	CbGpPWpGaD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000232	0.00697	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000229	0.00688	CbGpPWpGaD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00019	0.0057	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—COMT—conduct disorder	0.000182	0.00546	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000181	0.00542	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.000179	0.00539	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000177	0.00531	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000176	0.00527	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000175	0.00525	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000173	0.0052	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000153	0.00459	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000153	0.00459	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000151	0.00455	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000148	0.00444	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—COMT—conduct disorder	0.000136	0.00407	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000135	0.00406	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000135	0.00404	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000135	0.00404	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000134	0.00401	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000133	0.00398	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000132	0.00396	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000132	0.00395	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000131	0.00393	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000131	0.00392	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00013	0.0039	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00013	0.00389	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.000124	0.00373	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.000123	0.0037	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.000123	0.00368	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000122	0.00365	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000114	0.00343	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000106	0.00317	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000102	0.00305	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000101	0.00303	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.0001	0.00301	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	9.92e-05	0.00298	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	9.76e-05	0.00293	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	9.76e-05	0.00293	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—COMT—conduct disorder	9.35e-05	0.00281	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.29e-05	0.00279	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—COMT—conduct disorder	9.27e-05	0.00278	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.22e-05	0.00277	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—MAOA—conduct disorder	9.21e-05	0.00276	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	9.16e-05	0.00275	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	9.14e-05	0.00274	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.65e-05	0.0026	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—COMT—conduct disorder	7.92e-05	0.00238	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.89e-05	0.00237	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.87e-05	0.00236	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.81e-05	0.00235	CbGpPWpGaD
Fluvoxamine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	7.62e-05	0.00229	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	7.53e-05	0.00226	CbGpPWpGaD
Fluvoxamine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	7.46e-05	0.00224	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CGA—conduct disorder	6.89e-05	0.00207	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.74e-05	0.00202	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—COMT—conduct disorder	6.11e-05	0.00184	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	6.07e-05	0.00182	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.03e-05	0.00181	CbGpPWpGaD
Fluvoxamine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	5.14e-05	0.00154	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CGA—conduct disorder	5.1e-05	0.00153	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CGA—conduct disorder	4.99e-05	0.0015	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CGA—conduct disorder	4.98e-05	0.0015	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CGA—conduct disorder	4.71e-05	0.00141	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.91e-05	0.00117	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CGA—conduct disorder	3.85e-05	0.00116	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CGA—conduct disorder	3.76e-05	0.00113	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CGA—conduct disorder	3.54e-05	0.00106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CGA—conduct disorder	3.51e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—COMT—conduct disorder	3.11e-05	0.000934	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MAOA—conduct disorder	3.09e-05	0.000927	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CGA—conduct disorder	3e-05	0.000901	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CGA—conduct disorder	2.32e-05	0.000695	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—COMT—conduct disorder	2.3e-05	0.000691	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOA—conduct disorder	2.29e-05	0.000686	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—COMT—conduct disorder	2.25e-05	0.000676	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—COMT—conduct disorder	2.25e-05	0.000675	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOA—conduct disorder	2.24e-05	0.000672	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOA—conduct disorder	2.23e-05	0.00067	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—COMT—conduct disorder	2.13e-05	0.000638	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOA—conduct disorder	2.11e-05	0.000633	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.05e-05	0.000614	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—COMT—conduct disorder	1.74e-05	0.000522	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOA—conduct disorder	1.73e-05	0.000518	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—COMT—conduct disorder	1.7e-05	0.000509	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOA—conduct disorder	1.69e-05	0.000506	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.67e-05	0.000503	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—conduct disorder	1.6e-05	0.00048	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOA—conduct disorder	1.59e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—conduct disorder	1.59e-05	0.000476	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOA—conduct disorder	1.57e-05	0.000472	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.53e-05	0.000458	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—conduct disorder	1.35e-05	0.000407	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOA—conduct disorder	1.35e-05	0.000404	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—EP300—conduct disorder	1.33e-05	0.0004	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.3e-05	0.000392	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—conduct disorder	1.05e-05	0.000314	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOA—conduct disorder	1.04e-05	0.000312	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—EP300—conduct disorder	9.87e-06	0.000296	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—EP300—conduct disorder	9.67e-06	0.00029	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—EP300—conduct disorder	9.65e-06	0.000289	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—EP300—conduct disorder	9.11e-06	0.000273	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—EP300—conduct disorder	7.46e-06	0.000224	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—EP300—conduct disorder	7.28e-06	0.000218	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—EP300—conduct disorder	6.86e-06	0.000206	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—EP300—conduct disorder	6.8e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—EP300—conduct disorder	5.81e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—EP300—conduct disorder	4.48e-06	0.000135	CbGpPWpGaD
